ctrl K

Watchlist Price Alert

Tvardi Therapeutics Inc. (TVRD)

NASDAQ: TVRD · Real-Time Price · USD

24.95

-0.01 (-0.04%)

At close: Jun 17, 2025, 2:03 PM

Tvardi Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Revenue	n/a	n/a
Cost of Revenue	n/a	n/a
Gross Profit	n/a	n/a
Operating Income	-18.66M	-21.19M
Interest Income	1.32M	654K
Pretax Income	-17.35M	-20.54M
Net Income	-17.35M	-20.54M
Selling & General & Admin	2.8M	2.73M
Research & Development	15.87M	18.47M
Other Expenses	n/a	n/a
Operating Expenses	18.66M	21.19M
Interest Expense	n/a	3K
Selling & Marketing Expenses	n/a	n/a
Cost & Expenses	18.66M	21.19M
Income Tax Expense	n/a	n/a
Shares Outstanding (Basic)	9.36M	9.36M
Shares Outstanding (Diluted)	9.36M	9.36M
EPS (Basic)	-1.85	-2.2
EPS (Diluted)	-1.85	-2.2
EBITDA	-17.25M	-20.45M
EBIT	-17.35M	-20.54M
Depreciation & Amortization	95K	85K